Asada H : VZV-specific cell-mediated immunity, but not humoral immunity, correlates inversely with the incidence of herpes zoster and the severity of skin symptoms and zoster-associated pain : The SHEZ study. Vaccine 2019 ; 37 : 6776-6781.
Oxman MN, Levin MJ, Johnson GR, et al : A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005 ; 352 : 2271-2284.
Oxman MN, Levin MJ, Shingles Prevention Study Group Vaccination against herpes zoster and postherpetic neuralgia. J Infect Dis 2008 ; 197 Suppl 2 (Suppl 2) : S228-S236.
Schmader KE, Levin MJ, Gnann Jr JW, et al: Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. Clin Infect Dis 2012 ; 54 : 922-928.
Berkowitz EM, Moyle G, Stellbrink HJ, et al : Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults : a phase 1/2a randomized, placebo-controlled study. J Infect Dis 2015 ; 211 : 1279-1287.